Boyan Litchev - Feb 1, 2022 Form 4 Insider Report for Indaptus Therapeutics, Inc. (INDP)

Role
Chief Medical Officer
Signature
/s/ Boyan Litchev
Stock symbol
INDP
Transactions as of
Feb 1, 2022
Transactions value $
$0
Form type
4
Date filed
2/2/2022, 06:08 PM
Previous filing
Dec 19, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INDP Stock Option (right to buy) Award $0 +90K $0.00 90K Feb 1, 2022 Common Stock 90K $4.97 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests and becomes exercisable as to one-third of the total shares on February 1, 2023 and thereafter the remaining shares vest and become exercisable in equal monthly installments over the following 24 months.